ONCTOncternal Therapeutics, Inc.

Nasdaq oncternal.com


$ 8.50 $ 0.49 (6 %)    

Thursday, 02-May-2024 10:23:46 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 8.745
$ 8.00
$ 8.85 x 100
$ 0.00 x 0
$ 8.00 - $ 8.50
$ 5.57 - $ 13.14
337
na
25.71M
$ 1.83
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-07-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 03-09-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 03-10-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-06-2021 03-31-2021 10-Q
13 03-11-2021 12-31-2020 10-K
14 11-04-2020 09-30-2020 10-Q
15 08-06-2020 06-30-2020 10-Q
16 05-07-2020 03-31-2020 10-Q
17 03-16-2020 12-31-2019 10-K
18 11-08-2019 09-30-2019 10-Q
19 08-09-2019 06-30-2019 10-Q
20 05-10-2019 03-31-2019 10-Q
21 03-18-2019 12-31-2018 10-K
22 11-08-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 03-13-2018 12-31-2017 10-K
26 11-14-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 05-15-2017 03-31-2017 10-Q
29 03-24-2017 12-31-2016 10-K
30 11-07-2016 09-30-2016 10-Q
31 08-09-2016 06-30-2016 10-Q
32 05-10-2016 03-31-2016 10-Q
33 03-15-2016 12-31-2015 10-K
34 11-09-2015 09-30-2015 10-Q
35 08-10-2015 06-30-2015 10-Q
36 05-11-2015 03-31-2015 10-Q
37 03-16-2015 12-31-2014 10-K
38 11-10-2014 09-30-2014 10-Q
39 08-05-2014 06-30-2014 10-Q
40 05-12-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 oncternal-announces-first-patient-dosed-in-fourth-cohort-of-phase-12-study-of-onct-534-for-the-treatment-of-rr-metastatic-castration-resistant-prostate-cancer

Oncternal Therapeutics, Inc. (NASDAQ:ONCT), a clinical-stage biopharmaceutical company focused on the development of novel onco...

 hc-wainwright--co-maintains-buy-on-oncternal-therapeutics-lowers-price-target-to-28

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Oncternal Therapeutics (NASDAQ:ONCT) with a Buy and lowers the ...

 insiders-buying-westlake-chemical-partners-and-2-other-stocks

Although U.S. stocks closed mostly lower on Monday, there were a few notable insider trades.

 oncternal-therapeutics-q4-2023-gaap-eps-3110-misses-3070-estimate-sales-297000k-beat-137500k-estimate

Oncternal Therapeutics (NASDAQ:ONCT) reported quarterly losses of $(3.110) per share which missed the analyst consensus estimat...

 earnings-scheduled-for-march-7-2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

 american-airlines-to-rally-around-32-here-are-10-top-analyst-forecasts-for-monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 hc-wainwright--co-maintains-buy-on-oncternal-therapeutics-raises-price-target-to-30

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Oncternal Therapeutics (NASDAQ:ONCT) with a Buy and raises the ...

 top-5-health-care-stocks-that-may-crash-this-month

As of Jan. 22, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as ...

 oncternal-therapeutics-inc-estimates-that-as-of-dec-31-2023-its-cash-and-cash-equivalents-were-343m

-SEC filing

 why-reneo-pharmaceuticals-shares-are-trading-higher-by-around-14-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an ac...

 why-ascent-industries-shares-are-trading-higher-by-7-here-are-20-stocks-moving-premarket

Shares of Ascent Industries Co. (NASDAQ: ACNT) rose sharply in pre-market trading as the company reported the sale of the busi...

 hc-wainwright--co-reiterates-buy-on-oncternal-therapeutics-maintains-2-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Oncternal Therapeutics (NASDAQ:ONCT) with a Buy and maintains ...

 why-rayzebio-shares-are-trading-higher-by-100-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acqui...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION